These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 24565773)
1. Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema. Bernstein JA; Manning ME; Li H; White MV; Baker J; Lumry WR; Davis-Lorton MA; Jacobson KW; Gower RG; Broom C; Fitts D; Schranz J J Allergy Clin Immunol Pract; 2014; 2(1):77-84. PubMed ID: 24565773 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of prophylactic nanofiltered C1-inhibitor in hereditary angioedema. Zuraw BL; Kalfus I Am J Med; 2012 Sep; 125(9):938.e1-7. PubMed ID: 22800873 [TBL] [Abstract][Full Text] [Related]
3. Thrombotic events associated with C1 esterase inhibitor products in patients with hereditary angioedema: investigation from the United States Food and Drug Administration adverse event reporting system database. Gandhi PK; Gentry WM; Bottorff MB Pharmacotherapy; 2012 Oct; 32(10):902-9. PubMed ID: 23033229 [TBL] [Abstract][Full Text] [Related]
4. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema. Lyseng-Williamson KA BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916 [TBL] [Abstract][Full Text] [Related]
5. Preventing Hereditary Angioedema Attacks in Children Using Cinryze®: Interim Efficacy and Safety Phase 3 Findings. Aygören-Pürsün E; Soteres D; Moldovan D; Christensen J; Van Leerberghe A; Hao J; Schranz J; Jacobson KW; Martinez-Saguer I Int Arch Allergy Immunol; 2017; 173(2):114-119. PubMed ID: 28662509 [TBL] [Abstract][Full Text] [Related]
6. Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children. Lumry W; Manning ME; Hurewitz DS; Davis-Lorton M; Fitts D; Kalfus IN; Uknis ME J Pediatr; 2013 May; 162(5):1017-22.e1-2. PubMed ID: 23312695 [TBL] [Abstract][Full Text] [Related]
7. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema. Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230 [TBL] [Abstract][Full Text] [Related]
8. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks. Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks. Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema. Lumry W; Soteres D; Gower R; Jacobson KW; Li HH; Chen H; Schranz J Pediatr Allergy Immunol; 2015 Nov; 26(7):674-80. PubMed ID: 26171584 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study. Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164 [TBL] [Abstract][Full Text] [Related]
12. Cinryze (C1-inhibitor) for the treatment of hereditary angioedema. Gompels MM; Lock RJ Expert Rev Clin Immunol; 2011 Sep; 7(5):569-73. PubMed ID: 21895469 [TBL] [Abstract][Full Text] [Related]